About
Welcome to CogniSci Labs
At CogniSci Labs, we’re revolutionizing the way we approach brain health. With our cutting-edge saliva-based test, powered by advanced cfDNA methylation analysis, we’re making early detection of neurodegenerative diseases like dementia accessible, non-invasive, and accurate.
Our Mission
Our mission is to empower individuals, families, and healthcare providers with actionable insights into cognitive health—helping to catch diseases earlier, improve treatment outcomes, and support groundbreaking advancements in drug development.
Revolutionizing cognitive health through accessible, non-invasive diagnostics.
CogniSci Labs provides a non-invasive saliva test that detects cfDNA methylation patterns to enable early detection of neurodegenerative diseases like dementia.
Our advanced analytics deliver personalized insights, empowering individuals to take proactive steps for better cognitive health. We also partner with pharmaceutical companies to support drug efficacy tracking and accelerate research in neurodegenerative disease treatment.
Early Detection
Identify cognitive decline at its earliest stages with our cutting-edge saliva-based test.
Precision Insights
Actionable results powered by advanced cfDNA methylation analysis, tailored to your needs.
Easy Accessibility
Test conveniently at home with a simple saliva sample—no needles, no stress.
Proactive Health Planning
SGet personalized recommendations to improve cognitive health and guide treatment decisions.
Dr. Jason Goodpaster
CEO, Founder.PhD Chemical Engineering (Caltech), 10+ years experience with multiple awards in ML/AI.
Stealth Cofounder
Chief Science Officer, FounderExperienced in building liquid biopsy diagnostics. Highly motivated to generate liquid biopsy diagnostics for Alzheimer’s/Frontotemporal Dementia.
Joon Yoo
CTO, Founder.Ex-Snowflake. Cloud architect. ML Ops. Experience in rapidly scaling technology teams and platforms in early startups and Fortune 100 companies.